COVID-19 Vaccine (inactivated, adjuvanted) Valneva European Union - English - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccines - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.

IXIARO SUSPENSION Canada - English - Health Canada

ixiaro suspension

valneva austria gmbh - inact.japanese encephal virus(attenuat. strain sa14-14-2 produced in vero cells) - suspension - 6mcg - inact.japanese encephal virus(attenuat. strain sa14-14-2 produced in vero cells) 6mcg - vaccines

Ixiaro European Union - English - EMA (European Medicines Agency)

ixiaro

valneva austria gmbh - japanese-encephalitis virus, inactivated (attenuated strain sa14-14-2 grown in vero cells) - encephalitis, japanese; immunization - vaccines - ixiaro is indicated for active immunisation against japanese encephalitis in adults, adolescents, children and infants aged two months and older.ixiaro should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.